Trial Profile
Investigation of Local Skin Reactions and Safety After Combined Treatment of Basal Cell Carcinoma Using Ablative Fractional Laser and Ingenol Mebutate - an Exploratory, Prospective, Open-label Phase 2a Trial
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Aug 2018
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Basal cell cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Jul 2018 New trial record